|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Barnholtz-Sloan JS, Sloan AE, Davis FG,
Vigneau FD, Lai P and Sawaya RE: Incidence proportions of brain
metastases in patients diagnosed (1973 to 2001) in the metropolitan
detroit cancer surveillance system. J Clin Oncol. 22:2865–2872.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lin NU, Amiri-Kordestani L, Palmieri D,
Liewehr DJ and Steeg PS: CNS metastases in breast cancer: Old
challenge, new frontiers. Clin Cancer Res. 19:6404–6418. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
DiStefano A, Yap Yong Y, Hortobagyi GN and
Blumenschein GR: The natural history of breast cancer patients with
brain metastases. Cancer. 44:1913–1918. 1979. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tabouret E, Metellus P, Goncalves A,
Esterni B, Charaffe-Jauffret E, Viens P and Tallet A: Assessment of
prognostic scores in brain metastases from breast cancer. Neuro
Oncol. 16:421–428. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Altundag K, Bondy ML, Mirza NQ, Kau SW,
Broglio K, Hortobagyi GN and Rivera E: Clinicopathologic
characteristics and prognostic factors in 420 metastatic breast
cancer patients with central nervous system metastasis. Cancer.
110:2640–2647. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gaspar L, Scott C, Rotman M, Asbell S,
Phillips T, Wasserman T, McKenna WG and Byhardt R: Recursive
partitioning analysis (RPA) of prognostic factors in three
radiation therapy oncology group (RTOG) brain metastases trials.
Int J Radiat Oncol Biol Phys. 37:745–751. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sperduto PW, Berkey B, Gaspar LE, Mehta M
and Curran W: A new prognostic index and comparison to three other
indices for patients with brain metastases: An analysis of 1,960
patients in the RTOG database. Int J Radiat Oncol Biol Phys.
70:510–514. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sperduto PW, Kased N, Roberge D, Xu Z,
Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, et al: Effect
of tumor subtype on survival and the graded prognostic assessment
for patients with breast cancer and brain metastases. Int J Radiat
Oncol Biol Phys. 82:2111–2117. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Iasonos A, Schrag D, Raj GV and Panageas
KS: How to build and interpret a nomogram for cancer prognosis. J
Clin Oncol. 26:1364–1370. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pietrantonio F, Aprile G, Rimassa L,
Franco P, Lonardi S, Cremolini C, Biondani P, Sbicego EL,
Pasqualetti F, Tomasello G, et al: A new nomogram for estimating
survival in patients with brain metastases secondary to colorectal
cancer. Radiother Oncol. 117:315–321. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Graesslin O, Abdulkarim BS, Coutant C,
Huguet F, Gabos Z, Hsu L, Marpeau O, Uzan S, Pusztai L, Strom EA,
et al: Nomogram to predict subsequent brain metastasis in patients
with metastatic breast cancer. J Clin Oncol. 28:2032–2037. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ahn HK, Lee S, Park YH, Sohn JH, Jo JC,
Ahn JH, Jung KH, Park S, Cho EY, Lee JI, et al: Prediction of
outcomes for patients with brain parenchymal metastases from breast
cancer (BC): A new BC-specific prognostic model and a nomogram.
Neuro Oncol. 14:1105–1113. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sternberg CN: Are nomograms better than
currently available stage groupings for bladder cancer? J Clin
Oncol. 24:3819–3820. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marko NF, Xu Z, Gao T, Kattan MW and Weil
RJ: Predicting survival in women with breast cancer and brain
metastasis: A nomogram outperforms current survival prediction
models. Cancer. 118:3749–3757. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang Y, Zhang YJ, Zhu Y, Cao JZ, Yuan ZY,
Xu LM, Wu JX, Wang W, Wu T, Lu B, et al: Prognostic nomogram for
overall survival in previously untreated patients with extranodal
NK/T-cell lymphoma, nasal-type: A multicenter study. Leukemia.
29:1571–1577. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang LQ, Li CF, Li J, Chen WH, Chen QY,
Yuan LX, Lai XP, He Y, Xu YX, Hu DP, et al: Establishment and
validation of prognostic nomograms for endemic nasopharyngeal
carcinoma. J Natl Cancer Inst. 108:pii: djv291. 2015.
|
|
18
|
Subbiah IM, Lei X, Weinberg JS, Sulman EP,
Chavez-MacGregor M, Tripathy D, Gupta R, Varma A, Chouhan J,
Guevarra RP, et al: Validation and development of a modified breast
graded prognostic assessment as a tool for survival in patients
with breast cancer and brain metastases. J Clin Oncol.
33:2239–2245. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dawood S, Gonzalez-Angulo AM, Albarracin
C, Yu TK, Hortobagyi GN, Buchholz TA and Woodward WA: Prognostic
factors of survival in the trastuzumab era among women with breast
cancer and brain metastases who receive whole brain radiotherapy: A
single-institution review. Cancer. 116:3084–3092. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kased N, Binder DK, McDermott MW, Nakamura
JL, Huang K, Berger MS, Wara WM and Sneed PK: Gamma Knife
radiosurgery for brain metastases from primary breast cancer. Int J
Radiat Oncol Biol Phys. 75:1132–1140. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Le Scodan R, Massard C, Jouanneau L,
Coussy F, Gutierrez M, Kirova Y, Lerebours F, Labib A and
Mouret-Fourme E: Brain metastases from breast cancer: Proposition
of new prognostic score including molecular subtypes and treatment.
J Neurooncol. 106:169–176. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schag CC, Heinrich RL and Ganz PA:
Karnofsky performance status revisited: Reliability, validity, and
guidelines. J Clin Oncol. 2:187–193. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Goldhirsch A, Wood WC, Coates AS, Gelber
RD, Thürlimann B and Senn HJ: Panel members: Strategies for
subtypes-dealing with the diversity of breast cancer: Highlights of
the St Gallen international expert consensus on the primary therapy
of early breast cancer 2011. Ann Oncol. 22:1736–1747. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Harrell FE Jr, Lee KL and Mark DB:
Multivariable prognostic models: Issues in developing models,
evaluating assumptions and adequacy, and measuring and reducing
errors. Stat Med. 15:361–387. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Harrell FE Jr, Lee KL, Califf RM, Pryor DB
and Rosati RA: Regression modelling strategies for improved
prognostic prediction. Stat Med. 3:143–152. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Coutant C, Olivier C, Lambaudie E,
Fondrinier E, Marchal F, Guillemin F, Seince N, Thomas V, Levêque
J, Barranger E, et al: Comparison of models to predict nonsentinel
lymph node status in breast cancer patients with metastatic
sentinel lymph nodes: A prospective multicenter study. J Clin
Oncol. 27:2800–2808. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Niwinska A and Murawska M: New breast
cancer recursive partitioning analysis prognostic index in patients
with newly diagnosed brain metastases. Int J Radiat Oncol Biol
Phys. 82:2065–2071. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kim HJ, Im SA, Keam B, Kim YJ, Han SW, Kim
TM, Oh DY, Kim JH, Lee SH, Chie EK, et al: Clinical outcome of
central nervous system metastases from breast cancer: Differences
in survival depending on systemic treatment. J Neurooncol.
106:303–313. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Dawood S, Broglio K, Esteva FJ, Ibrahim
NK, Kau SW, Islam R, Aldape KD, Yu TK, Hortobagyi GN and
Gonzalez-Angulo AM: Defining prognosis for women with breast cancer
and CNS metastases by HER2 status. Ann Oncol. 19:1242–1248. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Le Scodan R, Jouanneau L, Massard C,
Gutierrez M, Kirova Y, Cherel P, Gachet J, Labib A and
Mouret-Fourme E: Brain metastases from breast cancer: Prognostic
significance of HER-2 overexpression, effect of trastuzumab and
cause of death. BMC Cancer. 11:3952011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lagerwaard FJ, Levendag PC, Nowak PJ,
Eijkenboom WM, Hanssens PE and Schmitz PI: Identification of
prognostic factors in patients with brain metastases: A review of
1292 patients. Int J Radiat Oncol Biol Phys. 43:795–803. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Balachandran VP, Gonen M, Smith JJ and
DeMatteo RP: Nomograms in oncology: More than meets the eye. Lancet
Oncol. 16:e173–e180. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chamberlain MC: Leptomeningeal metastases
in the MRI era. Neurology. 76:200author reply 200. –201. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kondziolka D, Kano H, Harrison GL, Yang
HC, Liew DN, Niranjan A, Brufsky AM, Flickinger JC and Lunsford LD:
Stereotactic radiosurgery as primary and salvage treatment for
brain metastases from breast cancer. Clinical article. J Neurosurg.
114:792–800. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Song WG, Wang YF, Wang RL, Qu YE, Zhang Z,
Li GZ, Xiao Y, Fang F and Chen H: Therapeutic regimens and
prognostic factors of brain metastatic cancers. Asian Pac J Cancer
Prev. 14:923–927. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Brower JV, Saha S, Rosenberg SA, Hullett
CR and Robins Ian H: Management of leptomeningeal metastases:
Prognostic factors and associated outcomes. J Clin Neurosci.
27:130–137. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Dayan A, Koca D, Akman T, Oztop I,
Ellidokuz H and Yilmaz U: The factors that have an impact on the
development of brain metastasis in the patients with breast cancer.
J Cancer Res Ther. 8:542–548. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Braccini AL, Azria D, Thezenas S, Romieu
G, Ferreri JM and Jacot W: Comparative performances of prognostic
indexes for breast cancer patients presenting with brain
metastases. BMC Cancer. 13:702013. View Article : Google Scholar : PubMed/NCBI
|
